Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of LY900014 in Participants With Type 1 Diabetes

ClinicalTrials.gov ID: NCT03214367

Public ClinicalTrials.gov record NCT03214367. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 4:01 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Randomized, Double-Blind Comparison of LY900014 to Insulin Lispro With an Open-Label Postprandial LY900014 Treatment Group, in Combination With Insulin Glargine or Insulin Degludec, in Adults With Type 1 Diabetes PRONTO-T1D

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The main purpose of this study is to evaluate the efficacy of the study drug LY900014 compared to insulin lispro, both in combination with insulin glargine or insulin degludec, in adults with type 1 diabetes (T1D).

Study identification

NCT ID
NCT03214367
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
1,392 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 17, 2017 (Actual)
Primary completion
Sep 6, 2018 (Actual)
Completion
Aug 22, 2019 (Actual)
Last update posted
May 1, 2020

2017 – 2019

United States locations

U.S. sites
44
U.S. states
23
U.S. cities
43
Facility City State ZIP Site status
Internal Medicine Center LLC Mobile Alabama 36608 —
John Muir Physician Network Clinical Research Center Concord California 94520 —
AMCR Institute INC Escondido California 92025 —
Valley Endocrine, Fresno Fresno California 93720 —
Marin Endocrine Associates Greenbrae California 94904 —
Diabetes and Endocrine Associates La Mesa California 91942 —
University Clinical Investigators, Inc. Tustin California 92780 —
Coastal Metabolic Research Centre Ventura California 93003 —
Barbara Davis Center for Childhood Diabetes Aurora Colorado 80045 —
The Center For Diabetes & Endocrine Care Fort Lauderdale Florida 33312 —
East Coast Institute For Research Jacksonville Florida 32204 —
Sun Coast Clinical Research, Inc New Port Richey Florida 34652 —
Metabolic Research Institute Inc. West Palm Beach Florida 33401 —
Atlanta Diabetes Associates Atlanta Georgia 30318 —
East Coast Institute For Research Macon Georgia 31210 —
Endocrine Research Solutions, Inc. Roswell Georgia 30076 —
East West Medical Institute Honolulu Hawaii 96814 —
Northwest Clinical Trials Boise Idaho 83704 —
Rocky Mountain Diabetes and Osteoporosis Center Idaho Falls Idaho 83404 —
Prairie Education and Research Cooperative Springfield Illinois 62711 —
Iderc, P.L.C. West Des Moines Iowa 50265 —
University of Kansas Medical Center Kansas City Kansas 66160 —
Cotton O'Neil Diabetes and Endocrinology Center Topeka Kansas 66606 —
Kentucky Diabetes Endocrinology Center Lexington Kentucky 40503 —
MassResearch Waltham Massachusetts 02453 —
Palm Research Center Las Vegas Nevada 89128 —
Palm Research Center Las Vegas Nevada 89148 —
Southern New Hampshire Diabetes and Endocrinology Nashua New Hampshire 03063 —
Manhattan Medical Research New York New York 10016 —
Physicians East Greenville North Carolina 27843 —
Diabetes & Endocrinology Consultants PC Morehead City North Carolina 28557 —
PMG Research of Wilmington, LLC Wilmington North Carolina 28401 —
Your Diabetes Endocrine Nutrition Group PC Mentor Ohio 44060 —
Lehigh Valley Hospital Allentown Pennsylvania 18103 —
Partners in Nephrology & Endocrinology Pittsburgh Pennsylvania 15224 —
Sudir Bansal M.D. Inc. Warwick Rhode Island 02886 —
University Diabetes and Endocrine Consultants Chattanooga Tennessee 37411 —
Texas Diabetes and Endocrinology Austin Texas 78731-4309 —
Dallas Diabetes Endocrine Center Dallas Texas 75230 —
Texas Diabetes and Endocrinology, P.A. Round Rock Texas 78681 —
Consano Clinical Research Shavano Park Texas 78231 —
Progressive Clinical Research Bountiful Utah 84010 —
Private: Dr. Larry Stonesifer Federal Way Washington 98003 —
Rainier Clinical Research Center Renton Washington 98057 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 128 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03214367, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 1, 2020 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03214367 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →